2026 -- H 7075

========

LC003546

========

     STATE OF RHODE ISLAND

IN GENERAL ASSEMBLY

JANUARY SESSION, A.D. 2026

____________

A N   A C T

RELATING TO INSURANCE -- ACCIDENT AND SICKNESS INSURANCE POLICIES --

THE MATTHEW FEDERICO DIABETIC SAFETY ACT

     

     Introduced By: Representatives McGaw, Shekarchi, Hull, Craven, Corvese, J. Lombardi,
Diaz, Donovan, and Kazarian

     Date Introduced: January 14, 2026

     Referred To: House Health & Human Services

     It is enacted by the General Assembly as follows:

1

     SECTION 1. The general assembly hereby finds and declares that:

2

     The Rhode Island general assembly recognizes that glucagon auto-injectors are life-saving

3

medications, that must be administered quickly to be effective. Such administration is often done

4

by persons who are not health care professionals, and is done in an emergency situation.

5

Accordingly, it is in the best interests of the people of the state to promote the widespread

6

availability of glucagon, that does not require reconstitution. Hypoglycemia, or low blood glucose,

7

is a barrier to diabetes control, leads to worse clinical outcomes, stress, increased cost of care and

8

polypharmacy. For unconscious patients, and those unable to ingest oral glucose, glucagon in the

9

ambulatory setting is indicated, but often underutilized, due to excessive cost.

10

     SECTION 2. Chapter 27-18 of the General Laws entitled "Accident and Sickness Insurance

11

Policies" is hereby amended by adding thereto the following section:

12

     27-18-96. Glucagon hypoglycemia medications.

13

     Every individual or group health insurance contract, plan, or policy that provides

14

prescription coverage and that is delivered, issued for delivery, prescribed, or renewed in this state

15

on or after January 1, 2027, shall provide coverage for at least one type of glucagon auto-injector,

16

nasal spray or formulation not requiring reconstitution. There shall be no copayment required and

17

no deductible shall need to be met, to obtain two (2) glucagon auto-injectors, nasal spray or non-

18

reconstituted formulation covered by the contract, plan, or policy, every twelve (12) month plan

 

1

year. A deductible may be applied to health plans that are paired with federally qualified health

2

savings account pursuant to 26 U.S.C § 223. Nothing in this section would prohibit a health plan

3

from implementing this benefit prior to January 1, 2027.

4

     SECTION 3. Chapter 27-19 of the General Laws entitled "Nonprofit Hospital Service

5

Corporations" is hereby amended by adding thereto the following section:

6

     27-19-88. Glucagon hypoglycemia medications.

7

     Every individual or group health insurance contract, plan, or policy that provides

8

prescription coverage and that is delivered, issued for delivery, prescribed, or renewed in this state

9

on or after January 1, 2027, shall provide coverage for at least one type of glucagon auto-injector,

10

nasal spray or formulation not requiring reconstitution. There shall be no copayment required and

11

no deductible shall need to be met, to obtain two (2) glucagon auto-injectors, nasal spray or non-

12

reconstituted formulation covered by the contract, plan, or policy, every twelve (12) month plan

13

year. A deductible may be applied to health plans that are paired with federally qualified health

14

savings account pursuant to 26 U.S.C § 223. Nothing in this section would prohibit a health plan

15

from implementing this benefit prior to January 1, 2027.

16

     SECTION 4. Chapter 27-20 of the General Laws entitled "Nonprofit Medical Service

17

Corporations" is hereby amended by adding thereto the following section:

18

     27-20-84. Glucagon hypoglycemia medications.

19

     Every individual or group health insurance contract, plan, or policy that provides

20

prescription coverage and that is delivered, issued for delivery, prescribed, or renewed in this state

21

on or after January 1, 2027, shall provide coverage for at least one type of glucagon auto-injector,

22

nasal spray or formulation not requiring reconstitution. There shall be no copayment required and

23

no deductible shall need to be met, to obtain two (2) glucagon auto-injectors, nasal spray or non-

24

reconstituted formulation covered by the contract, plan, or policy, every twelve (12) month plan

25

year. A deductible may be applied to health plans that are paired with federally qualified health

26

savings account pursuant to 26 U.S.C § 223. Nothing in this section would prohibit a health plan

27

from implementing this benefit prior to January 1, 2027.

28

     SECTION 5. Chapter 27-41 of the General Laws entitled "Health Maintenance

29

Organizations" is hereby amended by adding thereto the following section:

30

     27-41-101. Glucagon hypoglycemia medications.

31

     Every individual or group health insurance contract, plan, or policy that provides

32

prescription coverage and that is delivered, issued for delivery, prescribed, or renewed in this state

33

on or after January 1, 2027, shall provide coverage for at least one type of glucagon auto-injector,

34

nasal spray or formulation not requiring reconstitution. There shall be no copayment required and

 

LC003546 - Page 2 of 4

1

no deductible shall need to be met, to obtain two (2) glucagon auto-injectors, nasal spray or non-

2

reconstituted formulation covered by the contract, plan, or policy, every twelve (12) month plan

3

year. A deductible may be applied to health plans that are paired with federally qualified health

4

savings account pursuant to 26 U.S.C § 223. Nothing in this section would prohibit a health plan

5

from implementing this benefit prior to January 1, 2027.

6

     SECTION 6. This act shall take effect upon passage.

========

LC003546

========

 

LC003546 - Page 3 of 4

EXPLANATION

BY THE LEGISLATIVE COUNCIL

OF

A N   A C T

RELATING TO INSURANCE -- ACCIDENT AND SICKNESS INSURANCE POLICIES --

THE MATTHEW FEDERICO DIABETIC SAFETY ACT

***

1

     This act would require, commencing January 1, 2027, group health plans and health

2

insurance issuers that provide prescription benefits to cover at least one type of glucagon auto-

3

injector, nasal spray, or formulation which does not require reconstitution to treat hypoglycemia

4

with two (2) glucagon auto-injectors every plan year. No copayment or deductible would be

5

required to obtain prescribed glucagon medications.

6

     This act would take effect upon passage.

========

LC003546

========

 

LC003546 - Page 4 of 4